secwatch.observer — SEC 8-K summary
======================================

Issuer:     Harpoon Therapeutics, Inc. (—)
CIK:        0001708493
Form:       8-K
Filed at:   2024-01-29T23:59:59+00:00
Accession:  0001193125-24-018159
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Harpoon Therapeutics amends Series A Preferred Stock certificate to reflect 1-for-10 reverse split
--------------------------------------------------------------------------------

- Filed Certificate of Amendment on January 26, 2024, adjusting Series A Preferred Stock for the 1-for-10 reverse stock split effective September 1, 2023.
- Amendment is administrative; no change to preferred stock rights, preferences, or limitations.
- Reverse stock split was previously completed; this filing updates the preferred stock certificate accordingly.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708493/000119312524018159/0001193125-24-018159-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708493/000119312524018159/d687029d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-018159

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer